Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention

NCT03966066 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Bronchiectasis

Interventions

DRUG: erythromycin

Sponsor

Beijing Children's Hospital